...
首页> 外文期刊>Chemical research in toxicology >Detection of Covalent Adducts to Cytochrome P450 3A4 Using Liquid Chromatography Mass Spectrometry
【24h】

Detection of Covalent Adducts to Cytochrome P450 3A4 Using Liquid Chromatography Mass Spectrometry

机译:液相色谱质谱法检测细胞色素P450 3A4的共价加合物

获取原文
获取原文并翻译 | 示例
           

摘要

Protein covalent labeling can be an undesirable property of compounds being studied in drug discovery programs.Identifying such compounds relies on the use of radiolabeled material,which requires an investment in time and resources not typically expended until later in the discovery process.We describe the detection of covalent adducts to cytochrome P450 3A4,the most abundant and important P450 from a human and drug discovery viewpoint,using liquid chromatography mas! spectrometry.The technique is illustrated using L-754,394 and 6',7'-dihydroxybergamottin,two known inhibitors of P450 3A4.Mass spectrometry of the intact apoprotein as well as the adducted protein is demonstrated.Such methodology may provide the means for screening compounds for covalent protein binding without the use of a radiolabel.It also provides direct information about mechanism-based inhibitors in terms of extent,stoichiometry,and nature of the adduct(s)(mass shift).This information may provide a means for understanding the mechanism of covalent labeling earlier in a drug discovery environment.
机译:蛋白质共价标记可能是药物发现计划中正在研究的化合物的不良特性。鉴定此类化合物依赖于放射性标记材料的使用,这需要投入时间和资源,通常在发现过程的后期才消耗掉。细胞色素P450 3A4(从人类和药物发现的角度来看最丰富和重要的P450)的共价加合物,使用液相色谱mass!使用两种已知的P450 3A4抑制剂L-754,394和6',7'-dihydroxybergamottin对该技术进行了说明。证明了完整脱辅基蛋白和加成蛋白的质谱图。这种方法学可以为筛选化合物提供方法无需使用放射性标记就可与共价蛋白结合。它还提供了基于机理的抑制剂的直接信息,包括范围,化学计量以及加合物的性质(质量转移)。药物发现环境中较早地进行共价标记的机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号